Normal human CD4+ helper T cells express Kv1.1 voltage-gated K+ channels, and selective Kv1.1 block in T cells induces by itself robust TNFα production and secretion and activation of the NF

详细信息    查看全文

• 作者：Barbara Fellerhoff-Losch ; Sergiy V. Korol ; Yonatan Ganor…
• 关键词：Autoimmune diseases ; Immunotherapy ; Inflammation ; Kv1.1 ; NFκB ; Non ; canonical pathway ; Pro ; inflammatory cytokines ; T cells ; TNFα ; Voltage ; gated potassium channels
• 刊名：Journal of Neural Transmission
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：123
• 期：3
• 页码：137-157
• 全文大小：2,350 KB
• 参考文献：Adelman JP, Bond CT, Pessia M, Maylie J (1995) Episodic ataxia results from voltage–dependent potassium channels with altered functions. Neuron 15:1449–1454CrossRef PubMed
  Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP (2001) TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4:1116–1122CrossRef PubMed
  Bagchi B, Al-Sabi A, Kaza S, Scholz D, O’Leary VB, Dolly JO, Ovsepian SV (2014) Disruption of myelin leads to ectopic expression of KV1.1 channels with abnormal conductivity of optic nerve axons in a cuprizone-induced model of demyelination. PLoS One 9:e87736PubMedCentral CrossRef PubMed
  Baugh JA, Bucala R (2001) Mechanisms for modulating TNF alpha in immune and inflammatory disease. Curr Opin Drug Discov Devel 4:635–650PubMed
  Beeton C, Barbaria J, Giraud P, Devaux J, Benoliel AM, Gola M, Sabatier JM, Bernard D, Crest M, Beraud E (2001) Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation. J Immunol 166:936–944CrossRef PubMed
  Browne DL, Gancher ST, Nutt JG, Brunt ER, Smith EA, Kramer P, Litt M (1994) Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 8:136–140CrossRef PubMed
  Cahalan MD, Chandy KG (2009) The functional network of ion channels in T lymphocytes. Immunol Rev 231:59–87PubMedCentral CrossRef PubMed
  Campbell SJ, Perry VH, Pitossi FJ, Butchart AG, Chertoff M, Waters S, Dempster R, Anthony DC (2005) Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. Am J Pathol 166:1487–1497PubMedCentral CrossRef PubMed
  Chandy KG, DeCoursey TE, Cahalan MD, McLaughlin C, Gupta S (1984) Voltage-gated potassium channels are required for human T lymphocyte activation. J Exp Med 160:369–385CrossRef PubMed
  Ciccone MM, Scicchitano P, Zito A, Cortese F, Boninfante B, Falcone VA, Quaranta VN, Ventura VA, Zucano A, Di Serio F, Damiani MF, Resta O (2014) Correlation between inflammatory markers of atherosclerosis and carotid intima-media thickness in obstructive sleep apnea. Molecules 19:1651–1662CrossRef PubMed
  D’Adamo MC, Gallenmuller C, Servettini I, Hartl E, Tucker SJ, Arning L, Biskup S, Grottesi A, Guglielmi L, Imbrici P, Bernasconi P, Di Giovanni G, Franciolini F, Catacuzzeno L, Pessia M, Klopstock T (2014) Novel phenotype associated with a mutation in the KCNA1(Kv1.1) gene. Front Physiol 5:525PubMedCentral PubMed
  DeCoursey TE, Chandy KG, Gupta S, Cahalan MD (1984) Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature 307:465–468CrossRef PubMed
  Demos MK, Macri V, Farrell K, Nelson TN, Chapman K, Accili E, Armstrong L (2009) A novel KCNA1 mutation associated with global delay and persistent cerebellar dysfunction. Mov Disord 24:778–782CrossRef PubMed
  Derudder E, Dejardin E, Pritchard LL, Green DR, Korner M, Baud V (2003) RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100. J Biol Chem 278:23278–23284CrossRef PubMed
  Deutsch C, Krause D, Lee SC (1986) Voltage-gated potassium conductance in human T lymphocytes stimulated with phorbol ester. J Physiol Lond 372:405–423PubMedCentral CrossRef PubMed
  Dinarello CA, Moldawer LL (2002) Proinflammatory and anti-inflammatory cytokines in rheumatoid arthritis. Amgen Inc., Thousand Oaks, CA
  Fellermann K (2013) Adverse events of tumor necrosis factor inhibitors. Dig Dis 31:374–378CrossRef PubMed
  Finsen B, Antel J, Owens T (2002) TNFalpha: kill or cure for demyelinating disease? Mol Psychiatry 7:820–821CrossRef PubMed
  Freedman BD, Fleischmann BK, Punt JA, Gaulton G, Hashimoto Y, Kotlikoff MI (1995) Identification of Kv1.1 expression by murine CD4-CD8- thymocytes. A role for voltage-dependent K+ channels in murine thymocyte development. J Biol Chem 270:22406–22411CrossRef PubMed
  Ganor Y, Besser M, Ben-Zakay N, Unger T, Levite M (2003) Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J Immunol 170:4362–4372CrossRef PubMed
  Grgic I, Wulff H, Eichler I, Flothmann C, Kohler R, Hoyer J (2009) Blockade of T-lymphocyte KCa3.1 and Kv1.3 channels as novel immunosuppression strategy to prevent kidney allograft rejection. Transplant Proc 41:2601–2606PubMedCentral CrossRef PubMed
  Grissmer S, Nguyen AN, Aiyar J, Hanson DC, Mather RJ, Gutman GA, Karmilowicz MJ, Auperin DD, Chandy KG (1994) Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol 45:1227–1234PubMed
  Grunhagen DJ, de Wilt JH, van Geel AN, Verhoef C, Eggermont AM (2009) Isolated limb perfusion with TNF-alpha and melphalan in locally advanced soft tissue sarcomas of the extremities. Recent Results Cancer Res 179:257–270CrossRef PubMed
  Gutman GA, Chandy KG, Adelman JP, Aiyar J, Bayliss DA, Clapham DE, Covarriubias M, Desir GV, Furuichi K, Ganetzky B, Garcia ML, Grissmer S, Jan LY, Karschin A, Kim D, Kuperschmidt S, Kurachi Y, Lazdunski M, Lesage F, Lester HA, McKinnon D, Nichols CG, O’Kelly I, Robbins J, Robertson GA, Rudy B, Sanguinetti M, Seino S, Stuehmer W, Tamkun MM, Vandenberg CA, Wei A, Wulff H, Wymore RS (2003) International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channels. Pharmacol Rev 55:583–586CrossRef PubMed
  Hart IK, Waters C, Vincent A, Newland C, Beeson D, Pongs O, Morris C, Newsom-Davis J (1997) Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol 41:238–246CrossRef PubMed
  Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR (2002) Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125:1887–1895CrossRef PubMed
  Harvey AL (2001) Twenty years of dendrotoxins. Toxicon 39:15–26CrossRef PubMed
  Hayes AJ, Neuhaus SJ, Clark MA, Thomas JM (2007) Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma. Ann Surg Oncol 14:230–238CrossRef PubMed
  Jan LY, Jan YN (2012) Voltage-gated potassium channels and the diversity of electrical signalling. J Physiol 590:2591–2599PubMedCentral CrossRef PubMed
  Jow F, Zhang ZH, Kopsco DC, Carroll KC, Wang K (2004) Functional coupling of intracellular calcium and inactivation of voltage-gated Kv1.1/Kvbeta1.1 A-type K+ channels. Proc Natl Acad Sci USA 101:15535–15540PubMedCentral CrossRef PubMed
  Koo GC, Blake JT, Talento A, Nguyen M, Lin S, Sirotina A, Shah K, Mulvany K, Hora D Jr, Cunningham P, Wunderler DL, McManus OB, Slaughter R, Bugianesi R, Felix J, Garcia M, Williamson J, Kaczorowski G, Sigal NH, Springer MS, Feeney W (1997) Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol 158:5120–5128PubMed
  Levite M, Cahalon L, Hershkoviz R, Steinman L, Lider O (1998) Neuropeptides, via specific receptors, regulate T cell adhesion to fibronectin. J Immunol 160:993–1000PubMed
  Levite M, Cahalon L, Peretz A, Hershkoviz R, Sobko A, Ariel A, Desai R, Attali B, Lider O (2000) Extracellular K(+) and opening of voltage-gated potassium channels activate T cell integrin function: physical and functional association between Kv1.3 channels and beta1 integrins. J Exp Med 191:1167–1176PubMedCentral CrossRef PubMed
  Li Y, Song D, Song Y, Zhao L, Wolkow N, Tobias JW, Song W, Dunaief JL (2015) Iron-induced local complement component 3 (C3) Up-regulation via non-canonical transforming growth factor (TGF)-beta signaling in the retinal pigment epithelium. J Biol Chem 290:11918–11934CrossRef PubMed
  Li Z, Liu WH, Han S, Peng BW, Yin J, Wu YL, He XH, Li WX (2012) Selective inhibition of CCR7(−) effector memory T cell activation by a novel peptide targeting Kv1.3 channel in a rat experimental autoimmune encephalomyelitis model. J Biol Chem 287:29479–29494PubMedCentral CrossRef PubMed
  Liu QH, Fleischmann BK, Hondowicz B, Maier CC, Turka LA, Yui K, Kotlikoff MI, Wells AD, Freedman BD (2002) Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4(+) lymphocyte differentiation. J Exp Med 196:897–909PubMedCentral CrossRef PubMed
  Lobo FM, Zanjani R, Ho N, Chatila TA, Fuleihan RL (1999) Calcium-dependent activation of TNF family gene expression by Ca2+/calmodulin kinase type IV/Gr and calcineurin. J Immunol 162:2057–2063PubMed
  Luckheeram RV, Zhou R, Verma AD, Xia B (2012) CD4(+)T cells: differentiation and functions. Clin Dev Immunol 2012:925135PubMedCentral CrossRef PubMed
  Magnotti F, Vitale A, Rigante D, Lucherini OM, Cimaz R, Muscari I, de Faria AGA, Frediani B, Galeazzi M, Cantarini L (2013) The most recent advances in pathophysiology and management of tumour necrosis factor receptor-associated periodic syndrome (TRAPS): personal experience and literature review. Clin Exp Rheumatol 31:141–149PubMed
  Malik M, Sheikh AM, Wen G, Spivack W, Brown WT, Li X (2011) Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects. Immunobiology 216:80–85CrossRef PubMed
  Mayhan WG (2002) Cellular mechanisms by which tumor necrosis factor-alpha produces disruption of the blood
  ain barrier. Brain Res 927:144–152CrossRef PubMed
  Moreno-Ramirez D, de la Cruz-Merino L, Ferrandiz L, Villegas-Portero R, Nieto-Garcia A (2010) Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety. Oncologist 15:416–427PubMedCentral CrossRef PubMed
  Orange JS, Levy O, Geha RS (2005) Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol Rev 203:21–37CrossRef PubMed
  Pan Y, Weng J, Cao Y, Bhosle RC, Zhou M (2008) Functional coupling between the Kv1.1 channel and aldoketoreductase Kvbeta1. J Biol Chem 283:8634–8642PubMedCentral CrossRef PubMed
  Rader RK, Kahn LE, Anderson GD, Martin CL, Chinn KS, Gregory SA (1996) T cell activation is regulated by voltage-dependent and calcium- activated potassium channels. J Immunol 156:1425–1430PubMed
  Robertson B, Owen D, Stow J, Butler C, Newland C (1996) Novel effects of dendrotoxin homologues on subtypes of mammalian Kv1 potassium channels expressed in Xenopus oocytes. FEBS Lett 383:26–30CrossRef PubMed
  Rossi CR, Pasquali S, Mocellin S, Vecchiato A, Campana LG, Pilati P, Zanon A, Nitti D (2010) Long-term results of melphalan-based isolated limb perfusion with or without low-dose TNF for in-transit melanoma metastases. Ann Surg Oncol 17:3000–3007CrossRef PubMed
  Ryan S, Taylor CT, McNicholas WT (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Postgrad Med J 85:693–698CrossRef PubMed
  Siebenlist U, Franzoso G, Brown K (1994) Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10:405–455CrossRef PubMed
  Simon A, Park H, Maddipati R, Lobito AA, Bulua AC, Jackson AJ, Chae JJ, Ettinger R, de Koning HD, Cruz AC, Kastner DL, Komarow H, Siegel RM (2010) Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome. Proc Natl Acad Sci USA 107:9801–9806PubMedCentral CrossRef PubMed
  Smart SL, Lopantsev V, Zhang CL, Robbins CA, Wang H, Chiu SY, Schwartzkroin PA, Messing A, Tempel BL (1998) Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 20:809–819CrossRef PubMed
  Song X, Fan X, Song X, Zhang J, Zhang W, Li X, Gao J, Harrington A, Ziedonis D, Lv L (2013) Elevated levels of adiponectin and other cytokines in drug naive, first episode schizophrenia patients with normal weight. Schizophr Res 150:269–273CrossRef PubMed
  Sun SC (2011) Non-canonical NF-kappaB signaling pathway. Cell Res 21:71–85PubMedCentral CrossRef PubMed
  Sun X, Zaydman MA, Cui J (2012) Regulation of voltage-activated K(+) channel gating by transmembrane beta subunits. Front Pharmacol 3:63PubMedCentral CrossRef PubMed
  Uno M, Saitoh Y, Mochida K, Tsuruyama E, Kiyono T, Imoto I, Inazawa J, Yuasa Y, Kubota T, Yamaoka S (2014) NF-kappaB inducing kinase, a central signaling component of the non-canonical pathway of NF-kappaB, contributes to ovarian cancer progression. PLoS One 9:e88347PubMedCentral CrossRef PubMed
  Upthegrove R, Manzanares-Teson N, Barnes NM (2014) Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis. Schizophr Res 155:101–108CrossRef PubMed
  Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, Clover L, Parkinson A, Bien CG, Omer S, Lang B, Rossor MN, Palace J (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127:701–712CrossRef PubMed
  Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17:331–367CrossRef PubMed
  Wu CY, Kaur C, Sivakumar V, Lu J, Ling EA (2009) Kv1.1 expression in microglia regulates production and release of proinflammatory cytokines, endothelins and nitric oxide. Neuroscience 158:1500–1508CrossRef PubMed
  Xiao G, Rabson AB, Young W, Qing G, Qu Z (2006) Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease. Cytokine Growth Factor Rev 17:281–293CrossRef PubMed
  Zhou L, Zhang CL, Messing A, Chiu SY (1998) Temperature-sensitive neuromuscular transmission in Kv1.1 null mice: role of potassium channels under the myelin sheath in young nerves. J Neurosci 18:7200–7215PubMed
  
• 作者单位：Barbara Fellerhoff-Losch (1)
  Sergiy V. Korol (2)
  Yonatan Ganor (3)
  Songhai Gu (4)
  Itzik Cooper (5)
  Raya Eilam (6)
  Michal Besser (7)
  Meidan Goldfinger (8)
  Yehuda Chowers (9)
  Rudolf Wank (4)
  Bryndis Birnir (2)
  Mia Levite (10) (11) (12)
  
  1. Immunis e.V. and Immunotherapy Research Center, Munich, Bavaria, Germany
  2. Department of Neuroscience, Uppsala University, Uppsala, Sweden
  3. Department of Infection, Immunity and Inflammation, Cochin Institute, CNRS UMR8104, INSERM U1016, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
  4. Immunotherapy Research Center, Munich, Bavaria, Germany
  5. The Joseph Sagol Neuroscience Center, Haim Sheba Medical Center, Tel Hashomer, Israel
  6. Veterinary Resources, The Weizmann Institute of Science, Rehovot, Israel
  7. Sheba Medical Center, The Ella Institute for Treatment and Research of Melanoma, Tel Hashomer, Israel
  8. Pain Medicine Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
  9. Department of Gastroenterology, Rambam Health Care Campus & Bruce Rappaport School of Medicine, Technion Institute of Technology, Haifa, Israel
  10. School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
  11. Institute of Gene Therapy, Hadassah University Hospital, Jerusalem, Israel
  12. School of Behavioral Sciences, Academic College of Tel Aviv-Jaffa, Tel Aviv, Israel
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Neurology
  Pharmacology and Toxicology
  Psychiatry
  
• 出版者：Springer Wien
• ISSN：1435-1463

文摘

TNFα is a very potent and pleiotropic pro-inflammatory cytokine, essential to the immune system for eradicating cancer and microorganisms, and to the nervous system, for brain development and ongoing function. Yet, excess and/or chronic TNFα secretion causes massive tissue damage in autoimmune, inflammatory and neurological diseases and injuries. Therefore, many patients with autoimmune/inflammatory diseases receive anti-TNFα medications. TNFα is secreted primarily by CD4+ T cells, macrophages, monocytes, neutrophils and NK cells, mainly after immune stimulation. Yet, the cause for the pathologically high and chronic TNFα secretion is unknown. Can blocking of a particular ion channel in T cells induce by itself TNFα secretion? Such phenomenon was never revealed or even hypothesized. In this interdisciplinary study we discovered that: (1) normal human T cells express Kv1.1 voltage-gated potassium channel mRNA, and the Kv1.1 membrane-anchored protein channel; (2) Kv1.1 is expressed in most CD4+CD3+ helper T cells (mean CD4+CD3+Kv1.1+ T cells of 7 healthy subjects: 53.09 ± 22.17 %), but not in CD8+CD3+ cytotoxic T cells (mean CD8+CD3+Kv1.1+ T cells: 4.12 ± 3.04 %); (3) electrophysiological whole-cell recordings in normal human T cells revealed Kv currents; (4) Dendrotoxin-K (DTX-K), a highly selective Kv1.1 blocker derived from snake toxin, increases the rate of rise and decay of Kv currents in both resting and activated T cells, without affecting the peak current; (5) DTX-K by itself induces robust TNFα production and secretion by normal human T cells, without elevating IFNγ, IL-4 and IL-10; (6) intact Ca2+ channels are required for DTX-induced TNFα secretion; (7) selective anti-Kv1.1 antibodies also induce by themselves TNFα secretion; (8) DTX-K activates NFκB in normal human T cells via the unique non-canonical-pathway; (9) injection of Kv1.1-blocked human T cells to SCID mice, causes recruitment of resident mouse cells into the liver, alike reported after TNFα injection into the brain. Based on our discoveries we speculate that abnormally blocked Kv1.1 in T cells (and other immune cells?), due to either anti-Kv1.1 autoimmune antibodies, or Kv1.1-blocking toxins alike DTX-K, or Kv1.1-blocking genetic mutations, may be responsible for the chronic/excessive TNFα in autoimmune/inflammatory diseases. Independently, we also hypothesize that selective block of Kv1.1 in CD4+ T cells of patients with cancer or chronic infectious diseases could be therapeutic, since it may: a. augment beneficial secretion and delivery of TNFα to the disease-affected sites; b. induce recruitment and extravasation of curative immune cells and factors; c. improve accessibility of drugs to the brain and few peripheral organs thanks to TNFα-induced increased permeability of organ’s barriers.